Chemoradiotherapy (Gemox Plus Helical Tomotherapy) for Unresectable Locally Advanced Pancreatic Cancer: A Phase II Study.

GEMOX neoadjuvant therapy pancreatic cancer radiotherapy

Journal

Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829

Informations de publication

Date de publication:
13 May 2019
Historique:
received: 16 04 2019
revised: 09 05 2019
accepted: 10 05 2019
entrez: 16 5 2019
pubmed: 16 5 2019
medline: 16 5 2019
Statut: epublish

Résumé

The aim of the study was to evaluate the safety and efficacy of a new chemo-radiotherapy regimen for patients with locally advanced pancreatic cancer (LAPC). Patients were treated as follows: gemcitabine 1000 mg/m

Identifiants

pubmed: 31086093
pii: cancers11050663
doi: 10.3390/cancers11050663
pmc: PMC6562444
pii:
doi:

Types de publication

Journal Article

Langues

eng

Commentaires et corrections

Type : ErratumIn

Déclaration de conflit d'intérêts

The authors declare no conflict of interest.

Références

Int J Radiat Oncol Biol Phys. 2004 Mar 15;58(4):1017-21
pubmed: 15001240
Int J Radiat Oncol Biol Phys. 2005 Oct 1;63(2):320-3
pubmed: 16168826
J Clin Oncol. 2007 Jan 20;25(3):326-31
pubmed: 17235048
Cancer. 2007 Jul 1;110(1):47-55
pubmed: 17538975
Int J Radiat Oncol Biol Phys. 2008 Nov 1;72(3):678-86
pubmed: 18395362
Ann Oncol. 2008 Sep;19(9):1592-9
pubmed: 18467316
Cancer. 2009 Feb 1;115(3):665-72
pubmed: 19117351
Int J Radiat Oncol Biol Phys. 2011 Sep 1;81(1):181-8
pubmed: 21549517
Int J Radiat Oncol Biol Phys. 2011 Nov 15;81(4):e615-22
pubmed: 21658854
Hepatogastroenterology. 2011 Mar-Apr;58(106):599-603
pubmed: 21661438
J Clin Oncol. 2011 Nov 1;29(31):4105-12
pubmed: 21969502
Cancer. 2012 Dec 1;118(23):5749-56
pubmed: 22605518
Int J Radiat Oncol Biol Phys. 2013 Jul 1;86(3):516-22
pubmed: 23562768
J Natl Compr Canc Netw. 2014 Aug;12(8):1083-93
pubmed: 25099441
Am J Clin Oncol. 2017 Apr;40(2):152-157
pubmed: 25171298
Cancer. 2015 Apr 1;121(7):1128-37
pubmed: 25538019
Acta Oncol. 2015 Jul;54(7):979-85
pubmed: 25734581
J Radiat Oncol. 2013 Dec;2(4):413-425
pubmed: 25755849
Ann Oncol. 2015 Sep;26 Suppl 5:v56-68
pubmed: 26314780
JAMA. 2016 May 3;315(17):1844-53
pubmed: 27139057
Lancet Oncol. 2016 Jun;17(6):801-810
pubmed: 27160474
Technol Cancer Res Treat. 2017 Jun;16(3):295-301
pubmed: 27311310
JAMA Oncol. 2017 Apr 1;3(4):524-548
pubmed: 27918777
Ann Oncol. 2017 Nov 1;28(11):2786-2792
pubmed: 28945895
J Natl Cancer Inst. 1988 Jul 20;80(10):751-5
pubmed: 2898536
Radiat Oncol. 2018 Jun 25;13(1):118
pubmed: 29940984
CA Cancer J Clin. 2019 Jan;69(1):7-34
pubmed: 30620402
Cancer. 1981 Oct 15;48(8):1705-10
pubmed: 7284971

Auteurs

Alessandro Passardi (A)

Department of Medical Oncology, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Via P. Maroncelli n. 40, 47014 Meldola, Italy. alessandro.passardi@irst.emr.it.

Emanuela Scarpi (E)

Unit of Biostatistics and Clinical Trials, IRST-IRCCS, Via P. Maroncelli n. 40, 47014 Meldola, Italy. emanuela.scarpi@irst.emr.it.

Elisa Neri (E)

Radiotherapy Unit, IRST-IRCCS, Via P. Maroncelli n. 40, 47014 Meldola, Italy. elisa.neri@irst.emr.it.

Elisabetta Parisi (E)

Radiotherapy Unit, IRST-IRCCS, Via P. Maroncelli n. 40, 47014 Meldola, Italy. elisabetta.parisi@irst.emt.it.

Giulia Ghigi (G)

Radiotherapy Unit, IRST-IRCCS, Via P. Maroncelli n. 40, 47014 Meldola, Italy. giulia.ghigi@irst.emr.it.

Giorgio Ercolani (G)

General and Oncologic Surgery Unit, Morgagni-Pierantoni Hospital, AUSL Romagna, Via C. Forlanini n. 34, 47121 Forlì, Italy. giorgio.ercolani@auslromagna.it.
Department of Medical and Surgical Sciences, University of Bologna, Via Massarenti n. 9, 40138 Bologna, Italy. giorgio.ercolani@auslromagna.it.

Andrea Gardini (A)

General and Oncologic Surgery Unit, Morgagni-Pierantoni Hospital, AUSL Romagna, Via C. Forlanini n. 34, 47121 Forlì, Italy. andrea.gardini@auslromagna.it.

Giuliano La Barba (G)

General and Oncologic Surgery Unit, Morgagni-Pierantoni Hospital, AUSL Romagna, Via C. Forlanini n. 34, 47121 Forlì, Italy. giuliano.labarba@tin.it.

Flavia Pagan (F)

Unit of Biostatistics and Clinical Trials, IRST-IRCCS, Via P. Maroncelli n. 40, 47014 Meldola, Italy. flavia.pagan@irst.emr.it.

Andrea Casadei-Gardini (A)

Department of Medical Oncology, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Via P. Maroncelli n. 40, 47014 Meldola, Italy. casadeigardini@gmail.com.

Martina Valgiusti (M)

Department of Medical Oncology, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Via P. Maroncelli n. 40, 47014 Meldola, Italy. martina.valgiusti@irst.emr.it.

Fabio Ferroni (F)

Radiology Unit, IRST IRCCS, Via P. Maroncelli n. 40, 47014 Meldola, Italy. fabio.ferroni@irst.emr.it.

Giovanni Luca Frassineti (GL)

Department of Medical Oncology, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Via P. Maroncelli n. 40, 47014 Meldola, Italy. luca.frassineti@irst.emr.it.

Antonino Romeo (A)

Radiotherapy Unit, IRST-IRCCS, Via P. Maroncelli n. 40, 47014 Meldola, Italy. antonino.romeo@irst.emt.it.

Classifications MeSH